Evidence
Am J Psychiatry. 2023 May 1;180(5):340-347. doi: 10.1176/appi.ajp.20230172.
ABSTRACT
Over the past decade, psychedelic compounds have emerged as potentially transformative therapeutics for a variety of intractable neuropsychiatric conditions. However, historically most of the basic science has utilized these compounds as probes to interrogate various endogenous neurotransmitter systems-mainly the serotonin 5-HT2A receptor. With the renewed interest in utilizing these compounds as therapeutics and the explosion in clinical trials, psychedelics have been purported to treat many neuropsychiatric disorders, including depression, cluster headaches, migraines, anxiety, and obsessive-compulsive disorder. It is therefore imperative to understand the biology and pharmacology behind their therapeutic mechanisms as well as expose any potential pitfalls in their widespread use as treatments. This review covers the latest advances in understanding the biological mechanisms, the newest efforts in drug discovery, and potential pitfalls when it comes to utilizing this class of compounds as emerging therapeutics.
PMID:37122272 | DOI:10.1176/appi.ajp.20230172
Estimated reading time: 3 minute(s)
Latest: Psychiatryai.com #RAISR4D Evidence
Cool Evidence: Engaging Young People and Students in Real-World Evidence
Real-Time Evidence Search [Psychiatry]
AI Research
Psychedelics as Transformative Therapeutics
🌐 90 Days
AI Virtual Reality Related Evidence Matrix
- Structural pharmacology and therapeutic potential of 5-methoxytryptamines
- Structural pharmacology and therapeutic potential of 5-methoxytryptamines
- Psychedelic Therapy: A Primer for Primary Care Clinicians-The Strengths, Weaknesses, Opportunities, and Threats of Psychedelic Therapeutics
- Discovery and in vitro Evaluation of Novel Serotonin 5-HT2A Receptor Ligands Identified Through Virtual Screening
- Efficacy and safety of psychedelics for the treatment of mental disorders: A systematic review and meta-analysis
- Efficacy and safety of psychedelics for the treatment of mental disorders: A systematic review and meta-analysis
- Past Is Prologue: Ethical Issues in Pediatric Psychedelics Research and Treatment
- Effects of classic psychedelic drugs on turbulent signatures in brain dynamics
- 4-Amidophenol Quinone Methide Precursors: Effective and Broad-Scope Nonoxime Reactivators of Organophosphorus-Inhibited Cholinesterases and Resurrectors of Organophosphorus-Aged Acetylcholinesterase
- Multi-target drugs for Alzheimer's disease
- The Developmental Trajectory to Cannabis Use Disorder
- The Developmental Trajectory to Cannabis Use Disorder
- In the new era of psychedelic assisted therapy: A systematic review of study methodology in randomized controlled trials
- The Influence of Parenting on Callous-Unemotional Traits and the Implications for the Causes and Treatment of Conduct Disorder
- The Influence of Parenting on Callous-Unemotional Traits and the Implications for the Causes and Treatment of Conduct Disorder
- Pharmacological fingerprint of antipsychotic drugs at the serotonin 5-HT2A receptor
- Primordial Origins of RNA Therapeutics
- The More Things Change .
- Network Connection Issues in ADHD
- Advances in Understanding Schizophrenia, ADHD, and ASD
- ADHD and ASD: Time to Split or Lump?
- Predicting Conversion to Psychosis: What Lies Beyond the Biomarkers?
- Neuromelanin-Sensitive MRI: A Biomarker for Treatment-Resistant Schizophrenia?
- Cognitive Remediation in Schizophrenia Spectrum Illness: Evidence for Treatment Persistence
- Aligning Stem Cell Models and Postmortem Studies to Query Striatal Neurodevelopment in Schizophrenia
- The advent of RNA-based therapeutics for metabolic syndrome and associated conditions: a comprehensive review of the literature
- Scoping Review: The Role of Psychedelics in the Management of Chronic Pain
- Effects and safety of transcranial direct current stimulation on multiple health outcomes: an umbrella review of randomized clinical trials
- XOB: A novel phenylalkylamine antagonist of 5-HT2A receptors and voltage-gated sodium channels
- Stutterers' experiences on classic psychedelics: A preliminary self-report study
- Psychedelic Therapy: A Primer for Primary Care Clinicians-Psilocybin
- Psilocybin restrains activity-based anorexia in female rats by enhancing cognitive flexibility: contributions from 5-HT1A and 5-HT2A receptor mechanisms
- Psilocybin restrains activity-based anorexia in female rats by enhancing cognitive flexibility: contributions from 5-HT1A and 5-HT2A receptor mechanisms
- RE104: Synthesis and Activity of a Novel Serotonergic Psychedelic Prodrug of 4-Hydroxy-N,N-diisopropyltryptamine
- Nutritional profiling and in silico analysis of pharmacological activities from local rice Pulu Mandoti fermented with Pleurotus spp
- Ethox Seminar – The Ethics of Transformative Experience and Psychotherapy
- Therapeutic potential of Bergenin in the management of neurological-based diseases and disorders
- Neuroimaging correlates of classical psychedelics effects: A systematic review
- Neuroimaging correlates of classical psychedelics effects: A systematic review
- Establishing connectivity through microdissections of midbrain stimulation-related neural circuits
- Establishing connectivity through microdissections of midbrain stimulation-related neural circuits
- A review of the ethnopharmacology, phytochemistry, pharmacology, pharmacokinetics and toxicology of Abri Herba (Ji-Gu-Cao)
- Clinical dimensions of people with co-occurring obsessive-compulsive and related disorders and multiple sclerosis: a scoping review protocol
- Cryo-EM structures elucidate the multiligand receptor nature of megalin
- Insomnia in Forensic Detainees: Is Salience Network the Common Pathway for Sleep, Neuropsychiatric, and Neurodegenerative Disorders?
- Genome-Wide Association Study of Treatment-Resistant Depression: Shared Biology With Metabolic Traits
- Genome-Wide Association Study of Treatment-Resistant Depression: Shared Biology With Metabolic Traits
- Phytocannabinoids in neuromodulation: from omics to epigenetics
- Natural compounds proposed for the management of non-alcoholic fatty liver disease
- Kaempferol efficacy in metabolic diseases: Molecular mechanisms of action in diabetes mellitus, obesity, non-alcoholic fatty liver disease, steatohepatitis, and atherosclerosis
- Affective disorders and the loudness dependence of the auditory evoked potential: Serotonin and beyond
- Population-based cohort study of Toxoplasma gondii P22 antibody positivity correlation with anxiety
- Role of Serotonylation and SERT Posttranslational Modifications in Alzheimer's Disease Pathogenesis
- AI in Pharma: Transforming Drug Discovery and Strategic Management with MYC-Modulating Compounds and BET Protein Inhibitors
- Considerations for biomarker strategies in clinical trials investigating tau-targeting therapeutics for Alzheimer's disease
- Crocin (bioactive compound of Crocus sativus L.) potently restores REM sleep deprivation-induced manic- and obsessive-compulsive-like behaviors in female rats
- An Extensive Review on Lung Cancer Therapeutics Using Machine Learning Techniques: State-of-the-art and Perspectives
- Integrated spatial metabolomics and transcriptomics decipher the hepatoprotection mechanisms of wedelolactone and demethylwedelolactone on non-alcoholic fatty liver disease
- Network pharmacology and experimental evidence: ERK/CREB/BDNF signaling pathway is involved in the antidepressive roles of Kaiyu Zhishen decoction
- Network pharmacology combined with molecular docking and experimental verification to elucidate the effect of flavan-3-ols and aromatic resin on anxiety
- From compulsivity to compulsion: the neural basis of compulsive disorders
- Generative design of compounds with desired potency from target protein sequences using a multimodal biochemical language model
- Orexins and primary headaches: an overview of the neurobiology and clinical impact
- Emerging drugs in phase II and III clinical development for the treatment of alcohol use disorder
Evidence Blueprint
Psychedelics as Transformative Therapeutics
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Psychedelics as Transformative Therapeutics
🌐 365 Days
AI Virtual Reality Related Evidence Matrix
- Structural pharmacology and therapeutic potential of 5-methoxytryptamines
- Structural pharmacology and therapeutic potential of 5-methoxytryptamines
- Psychedelic Therapy: A Primer for Primary Care Clinicians-The Strengths, Weaknesses, Opportunities, and Threats of Psychedelic Therapeutics
- Psychedelic Drugs or Hallucinogens: Exploring Their Medicinal Potential
- Perceptual Modifying Compounds and Their Potential Therapeutic Applications in Neuropsychiatric Disorders
- Bedside to bench: the outlook for psychedelic research
- Overview of Alcohol Use Disorder
- Addressing the Current Knowledge and Gaps in Research Surrounding Lysergic Acid Diethylamide (LSD), Psilocybin, and Psilocin in Rodent Models
- Cerebrovascular Disease and Neuropsychiatric Disorders: Translating Findings From the MRI Scanner to the Clinic
- The Psychedelic Future of Post-Traumatic Stress Disorder Treatment
- Psychedelics for Alzheimer's Disease-Related Dementia: Unveiling Therapeutic Possibilities and Pathways
- Therapeutic potential of stilbenes in neuropsychiatric and neurological disorders: A comprehensive review of preclinical and clinical evidence
- Psychedelics reopen the social reward learning critical period
- Mechanisms and molecular targets surrounding the potential therapeutic effects of psychedelics
- Classical psychedelics in psychiatry - renaissance of interest and therapeutic perspectives
- Multimodal Neuroimaging of the Effect of Serotonergic Psychedelics on the Brain
- Discovery and in vitro Evaluation of Novel Serotonin 5-HT2A Receptor Ligands Identified Through Virtual Screening
- Cardiovascular safety of psychedelic medicine: current status and future directions
- RNA therapeutics for neurological disease
- Substance Use Disorders Are Psychiatric Disorders
- Isolating Socioenvironmental Correlates of Race/Ethnicity: A Promising Strategy to Understand and Address Health Disparities
- Rethinking the First Episode of Schizophrenia: Identifying Convergent Mechanisms During Development and Moving Toward Prediction
- New Insights Into Psychotic Disorders
- The First Large GWAS Meta-Analysis for Postpartum Depression
- Adversity and Resilience, Postpartum Depression, Suicide, and Racial/Ethnic Disparities
- Improvement in OCD symptoms associated with serotoninergic psychedelics: a retrospective online survey
- Seeking New Solutions Addressing Structural Racism, Childhood Trauma, Suicidal Behaviors Across Sexual Orientations, and Postpartum Depression
- Efficacy and safety of psychedelics for the treatment of mental disorders: A systematic review and meta-analysis
- Psychedelia: The interplay of music and psychedelics
- Alcohol Consumption and Alcohol Use Disorder: Exposing an Increasingly Shared Genetic Architecture
- Efficacy and safety of psychedelics for the treatment of mental disorders: A systematic review and meta-analysis
- Correction to Guintivano et al
- Molecular and Medical Aspects of Psychedelics
- Sutton's Law
- Sexual Orientation and Suicidal Behavior: Is It Getting Better?
- Past Is Prologue: Ethical Issues in Pediatric Psychedelics Research and Treatment
- Predicting Conversion to Psychosis Using Machine Learning: Are We There Yet?
- Perinatal Mental Health: Advances and Opportunities
- Another Step Toward the Prediction of Antipsychotic Treatment Response Using Functional Connectivity
- Trends in Suicide Among Black Women in the United States, 1999-2020
- Early-life Adversity and Genetics Associated With the Risk to Develop Psychiatric Illnesses
- A Mental Health Crisis and Call to Action: Increasing Trends in Suicide Among Black Women in the United States
- From Postmortem Molecular Studies to Social Determinants of Health Relevant to Racial and Ethnic Disparities
- Neuropsychiatric Manifestations of Mast Cell Activation Syndrome and Response to Mast-Cell-Directed Treatment: A Case Series
- Dissecting the Relationship Between Neuropsychiatric and Neurodegenerative Disorders
- Psychedelics, Meaningfulness, and the "Proper Scope" of Medicine: Continuing the Conversation
- Addiction specialists' attitudes toward psychedelics: A National Survey
- The bodily self from psychosis to psychedelics
- Effects of classic psychedelic drugs on turbulent signatures in brain dynamics
- 4-Amidophenol Quinone Methide Precursors: Effective and Broad-Scope Nonoxime Reactivators of Organophosphorus-Inhibited Cholinesterases and Resurrectors of Organophosphorus-Aged Acetylcholinesterase
- Multi-target drugs for Alzheimer's disease
- Modulation of neural circuits by melatonin in neurodegenerative and neuropsychiatric disorders
- Psychedelics to Relieve Psychological Suffering Associated with a Life-Threatening Diagnosis: Time for a Canadian Policy Discussion
- Identification of drug repurposing candidates for the treatment of anxiety: A genetic approach
- The Developmental Trajectory to Cannabis Use Disorder
- The Developmental Trajectory to Cannabis Use Disorder
- Psychedelics and neonihilism: connectedness in a meaningless world
- In the new era of psychedelic assisted therapy: A systematic review of study methodology in randomized controlled trials
- Molecular Mechanism Pathways of Natural Compounds for the Treatment of Non-Alcoholic Fatty Liver Disease
- Novel neurosteroid therapeutics for post-partum depression: perspectives on clinical trials, program development, active research, and future directions
- Pharmacology of platelet immune receptors: mechanisms of activation and development of therapeutics
- The Influence of Parenting on Callous-Unemotional Traits and the Implications for the Causes and Treatment of Conduct Disorder
- Are "mystical experiences" essential for antidepressant actions of ketamine and the classic psychedelics?
- The Influence of Parenting on Callous-Unemotional Traits and the Implications for the Causes and Treatment of Conduct Disorder